{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:38:25Z","timestamp":1790019505394,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T00:00:00Z","timestamp":1249603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00259-009-1204-z","type":"journal-article","created":{"date-parts":[[2009,8,6]],"date-time":"2009-08-06T12:00:00Z","timestamp":1249560000000},"page":"49-57","source":"Crossref","is-referenced-by-count":103,"title":["Comparison of 68Ga-DOTATATE and 18F-fluorodeoxyglucose PET\/CT in the detection of recurrent medullary thyroid carcinoma"],"prefix":"10.1007","volume":"37","author":[{"given":"Brendon G.","family":"Conry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos D.","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Kayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Caplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshed B.","family":"Bomanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,7]]},"reference":[{"key":"1204_CR1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ecl.2007.04.001","volume":"36","author":"DW Ball","year":"2007","unstructured":"Ball DW. Medullary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am 2007;36:823\u201337. viii.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1204_CR2","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1210\/jc.2002-021713","volume":"88","author":"C Scollo","year":"2003","unstructured":"Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 2003;88:2070\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"1204_CR3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00000658-199906000-00016","volume":"229","author":"JF Moley","year":"1999","unstructured":"Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 1999;229:880\u20137. discussion 887\u20138.","journal-title":"Ann Surg"},{"key":"1204_CR4","first-page":"67","volume":"33","author":"V Rufini","year":"2008","unstructured":"Rufini V, Treglia G, Perotti G, Leccisotti L, Calcagni ML, Rubello D. Role of PET in medullary thyroid carcinoma. Minerva Endocrinol 2008;33:67\u201373.","journal-title":"Minerva Endocrinol"},{"key":"1204_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/jc.2003-030550","volume":"89","author":"R Elisei","year":"2004","unstructured":"Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004;89:163\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1204_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopha.2007.07.011","volume":"62","author":"V Rufini","year":"2008","unstructured":"Rufini V, Castaldi P, Treglia G, Perotti G, Gross MD, Al-Nahhas A, et al. Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma. Biomed Pharmacother 2008;62:139\u201346.","journal-title":"Biomed Pharmacother"},{"key":"1204_CR7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","volume":"88","author":"E Kebebew","year":"2000","unstructured":"Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000;88:1139\u201348.","journal-title":"Cancer"},{"key":"1204_CR8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2008.03.001","volume":"37","author":"C Jim\u00e9nez","year":"2008","unstructured":"Jim\u00e9nez C, Hu MI, Gagel RF. Management of medullary thyroid carcinoma. Endocrinol Metab Clin North Am 2008;37:481\u201396. x-xi.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1204_CR9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1245\/ASO.2004.10.015","volume":"11","author":"JW Groot de","year":"2004","unstructured":"de Groot JW, Links TP, Jager PL, Kahraman T, Plukker JT. Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 2004;11:786\u201394.","journal-title":"Ann Surg Oncol"},{"key":"1204_CR10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2967\/jnumed.107.047720","volume":"49","author":"KP Koopmans","year":"2008","unstructured":"Koopmans KP, de Groot JW, Plukker JT, de Vries EG, Kema IP, Sluiter WJ, et al. 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation. J Nucl Med 2008;49:524\u201331.","journal-title":"J Nucl Med"},{"key":"1204_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1148\/radiol.2382041977","volume":"238","author":"GK Schulthess von","year":"2006","unstructured":"von Schulthess GK, Steinert HC, Hany TF. Integrated PET\/CT: current applications and future directions. Radiology 2006;238:405\u201322.","journal-title":"Radiology"},{"key":"1204_CR12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.106.036681","volume":"48","author":"SC Ong","year":"2007","unstructured":"Ong SC, Sch\u00f6der H, Patel SG, Tabangay-Lim IM, Doddamane I, G\u00f6nen M, et al. Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med 2007;48:501\u20137.","journal-title":"J Nucl Med"},{"key":"1204_CR13","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1210\/jc.2006-0334","volume":"91","author":"MC Zatelli","year":"2006","unstructured":"Zatelli MC, Piccin D, Tagliati F, Bottoni A, Luchin A, Vignali C, et al. Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. J Clin Endocrinol Metab 2006;91:2218\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"1204_CR14","first-page":"2417","volume":"83","author":"E Mato","year":"1998","unstructured":"Mato E, Matias-Guiu X, Chico A, Webb SM, Cabezas R, Bern\u00e1 L, et al. Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma. J Clin Endocrinol Metab 1998;83:2417\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"1204_CR15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2265.2001.01175.x","volume":"54","author":"M Papotti","year":"2001","unstructured":"Papotti M, Kumar U, Volante M, Pecchioni C, Patel YC. Immunohistochemical detection of somatostatin receptor types 1\u20135 in medullary carcinoma of the thyroid. Clin Endocrinol 2001;54:641\u20139.","journal-title":"Clin Endocrinol"},{"key":"1204_CR16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","volume":"27","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000;27:273\u201382.","journal-title":"Eur J Nucl Med"},{"key":"1204_CR17","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.23469","volume":"112","author":"I Kayani","year":"2008","unstructured":"Kayani I, Bomanji JB, Groves A, Conway G, Gacinovic S, Win T, et al. Functional imaging of neuroendocrine tumors with combined PET\/CT using 68Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 2008;112:2447\u201355.","journal-title":"Cancer"},{"key":"1204_CR18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/j.semnuclmed.2006.03.007","volume":"36","author":"V Rufini","year":"2006","unstructured":"Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med 2006;36:228\u201347.","journal-title":"Semin Nucl Med"},{"key":"1204_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ncpendmet1023","volume":"5","author":"G Costante","year":"2009","unstructured":"Costante G, Durante C, Francis Z, Schlumberger M, Filetti S. Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls. Nat Clin Pract Endocrinol Metab 2009;5:35\u201344.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1204_CR20","first-page":"70","volume":"26","author":"TM Behr","year":"1999","unstructured":"Behr TM, Becker W. Metabolic and receptor imaging of metastatic medullary thyroid cancer: does anti-CEA and somatostatin-receptor scintigraphy allow for prognostic predictions? Eur J Nucl Med 1999;26:70\u20131.","journal-title":"Eur J Nucl Med"},{"key":"1204_CR21","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1210\/jc.2007-1211","volume":"92","author":"AL Giraudet","year":"2007","unstructured":"Giraudet AL, Vanel D, Leboulleux S, Auperin A, Dromain C, Chami L, et al. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 2007;92:4185\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"1204_CR22","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s002590100614","volume":"28","author":"M Diehl","year":"2001","unstructured":"Diehl M, Risse JH, Brandt-Mainz K, Dietlein M, Bohuslavizki KH, Matheja P, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med 2001;28:1671\u20136.","journal-title":"Eur J Nucl Med"},{"key":"1204_CR23","first-page":"66","volume":"43","author":"S Szakall Jr","year":"2002","unstructured":"Szakall S Jr, Esik O, Bajzik G, Repa I, Dabasi G, Sinkovics I, et al. 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. J Nucl Med 2002;43:66\u201371.","journal-title":"J Nucl Med"},{"key":"1204_CR24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11307-006-0072-1","volume":"9","author":"A Iagaru","year":"2007","unstructured":"Iagaru A, Masamed R, Singer PA, Conti PS. Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET\/CT. Mol Imaging Biol 2007;9:72\u20137.","journal-title":"Mol Imaging Biol"},{"key":"1204_CR25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0039-6060(97)90208-7","volume":"122","author":"TJ Musholt","year":"1997","unstructured":"Musholt TJ, Musholt PB, Dehdashti F, Moley JF. Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study. Surgery 1997;122:1049\u201360. discussion 1060\u20131.","journal-title":"Surgery"},{"key":"1204_CR26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/02841860701441848","volume":"46","author":"M Essen Van","year":"2007","unstructured":"Van Essen M, Krenning EP, De Jong M, Valkema R, Kwekkeboom DJ. Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours. Acta Oncol 2007;46:723\u201334.","journal-title":"Acta Oncol"},{"key":"1204_CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/108497804773391694","volume":"19","author":"L Bodei","year":"2004","unstructured":"Bodei L, Handkiewicz-Junak D, Grana C, Mazzetta C, Rocca P, Bartolomei M, et al. Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas. Cancer Biother Radiopharm 2004;19:65\u201371.","journal-title":"Cancer Biother Radiopharm"},{"key":"1204_CR28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00006231-200106000-00011","volume":"22","author":"C Waldherr","year":"2001","unstructured":"Waldherr C, Schumacher T, Pless M, Crazzolara A, Maecke HR, Nitzsche EU, et al. Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using [90Y]-DOTA-D-Phe1-Tyr3-octrotide: a pilot study. Nucl Med Commun 2001;22:673\u20138.","journal-title":"Nucl Med Commun"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1204-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1204-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1204-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:01:48Z","timestamp":1558713708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1204-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1204-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,7]]}}}